AKT1 and breast cancer: CO-IP assay results showed that PB could block the binding of TRIB3 to AKT1; in vitro experiments confirmed that PB could inhibit the proliferation and migration of BC cells, and in vivo further confirmed that PB could inhibit the lung metastasis of BC.